Xiaoran Cui

8PUBLICATIONS
17CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityCellular interactions (incl. adhesion, matrix, cell wall)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 03, 2026
Recruited Monocyte-Derived Macrophages Drive T Cell Inflammation in Immune Checkpoint Inhibitor-Mediated Pneumonitis.

|Apr 13, 2026
Real-world efficacy and safety of disitamab vedotin (RC48) plus PD-1 inhibitors in advanced urothelial carcinoma: a single-center retrospective study.

Ya-Hui Lv, Xiao-Ran Cui, Lu Yu

|Mar 02, 2026
Efficacy and safety of immunotherapy in elderly patients with advanced non-small cell lung cancer: a real-world study stratified by age.

Yi Dong, Mei-Cen Liu, Yun-Ye Mao

|Oct 14, 2025
The NLRP3 inflammasome: a pivotal orchestrator of multisystem diseases-from molecular mechanisms to therapeutic innovation.

Shu-Yan Xiao, Ya-Hui Lv, Yin-Min Ji

|Jun 23, 2025
Neutrophil Extracellular Traps (NETs) in Sterile Inflammatory Diseases.

Yin-Min Ji, Tao Li, Yu-Hui Qin

|May 04, 2025
Mechanism of action and future perspectives of ADCs in combination with immune checkpoint inhibitors for solid tumors.

Yahui Lv, Xiaoran Cui, Tao Li

Pageof 2

Frequent Collaborators

6 joint publications

Yi Hu

5 joint publications

Tao Li

2 joint publications

Masayuki Mori

2 joint publications

Keiichi Higuchi